LAILA RAHBAR MD NPI 1417140864

NPI Information

  • NPI: 1417140864
  • Provider Name: LAILA RAHBAR, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 329 MCLAWS CIR
    WILLIAMSBURG, VA
    ZIP 23185
  • Phone: (757) 220-8579

Map and Directions

Get Directions

NPI Details

Laila Rahbar, MD is a rheumatology internal medicine in Williamsburg, VA with 20 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Laila Rahbar, MD NPI is 1417140864. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: WAKE FOREST UNIVERSITY SCHOOL OF MEDICINE
Graduation Year:2006

The provider's business location address is:

329 MCLAWS CIR
WILLIAMSBURG, VA
ZIP 23185-337
Phone: (757) 220-8579

The NPI 1417140864 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, tildrakizumab, 1 mg (HCPCS:J3245)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Methotrexate sodium, 50 mg (HCPCS:J9260)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
  • Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
  • Administration of pneumococcal vaccine (HCPCS:G0009)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Pneumococcal vaccine, 23-valent (HCPCS:90732)
  • Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)

The enumeration date for this NPI number is 8/20/2007 and was last updated on 11/19/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatology0101254212VIRGINIAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.